Director Sean Traynor awarded 2,340 AMERISAFE (AMSF) shares, lifting holdings

Rhea-AI Filing Summary

TRAYNOR SEAN reported acquisition or exercise transactions in this Form 4 filing.

AMERISAFE INC director Sean Traynor received a stock award of 2,340 shares of common stock. The shares were granted at no cash cost as a compensation-related award and are subject to restrictions that will lapse at the time of the company’s 2027 annual meeting of shareholders.

Following this grant, Traynor directly holds a total of 18,326 AMERISAFE common shares, reflecting a routine increase in his equity stake tied to board service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider TRAYNOR SEAN

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.01	2,340	$0.00	--

Holdings After Transaction: Common stock, par value $0.01 — 18,326 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant: 2,340 shares Post-transaction holdings: 18,326 shares Grant price: $0.00 per share +1 more

4 metrics

Stock grant 2,340 shares Compensation-related award on 2026-06-10

Post-transaction holdings 18,326 shares Direct ownership after grant

Grant price $0.00 per share Recorded transaction price for the award

Restriction lapse timing Issuer's 2027 annual meeting Restrictions lapse at 2027 annual meeting of shareholders

Key Terms

Grant, award, or other acquisition, annual meeting of shareholders, Common stock, par value $0.01, Form 4

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

annual meeting of shareholders regulatory

"restrictions that will lapse at the time of the Issuer's 2027 annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Common stock, par value $0.01 financial

"security_title: "Common stock, par value $0.01""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TRAYNOR SEAN

(Last) (First) (Middle)

599 LEXINGTON AVENUE 18TH FLOOR

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMERISAFE INC [ AMSF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.01	06/10/2026		A		2,340(1)	A	$0	18,326	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Subject to restrictions that will lapse at the time of the Issuer's 2027 annual meeting of shareholders.

	/s/ Kathryn H. Shirley, attorney-in-fact for Sean Traynor	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AMERISAFE (AMSF) director Sean Traynor report?

Sean Traynor reported receiving a grant of 2,340 shares of AMERISAFE common stock. The award was recorded at a price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase or sale.

How many AMERISAFE (AMSF) shares does Sean Traynor hold after this Form 4?

After the reported grant, Sean Traynor directly holds 18,326 AMERISAFE common shares. This total includes the newly awarded 2,340 shares and represents his direct ownership position as reported in the Form 4 insider filing.

What are the restrictions on Sean Traynor’s new AMERISAFE (AMSF) stock award?

The 2,340-share award to Sean Traynor is subject to restrictions that will lapse at the time of AMERISAFE’s 2027 annual meeting of shareholders. Until then, the shares remain restricted under the terms described in the Form 4 footnote.

Was Sean Traynor’s AMERISAFE (AMSF) Form 4 a market buy or sell?

The Form 4 reports a grant coded as “A,” described as a grant, award, or other acquisition. It is a compensation-related stock award at $0.00 per share, not an open-market purchase or sale transaction in AMERISAFE stock.

Does the AMERISAFE (AMSF) Form 4 show any stock sales by Sean Traynor?

The data show only one transaction: an acquisition of 2,340 shares classified as a grant or award. The transaction summary lists zero sales or dispositions, indicating no reported stock sales by Sean Traynor in this filing.